Sergio Amaro (SA) is a stroke neurologist of the CSC-HCB. During the last years he has participated in different funded research projects by Instituto de Salud Carlos III (ISCIIII), European research projects and in cooperative nets for investigation (RETICS-Invictus). From 2011, he is an accredited researcher of the Institut d’Investigacions Biomèdicas Augusti Pi I Sunyer (IDIBAPS) where he is integrated into the ‘Stroke Translational Research Group on Clinical and Experimental Studies’. He has taken part as first author or co-author in over 50 publications in indexed international journals in the field. Moreover, he has acted as an external reviewer of the National Evaluation and Prospective Agency and of original papers in international journals. SA did his specialty as a Neurologist in Hospital Clinic and afterwards he performed predoctoral and postdoctoral research projects in the Stroke Unit in the same hospital and in the Department of Cerebral Ischemia and Neurodegeneration of IIBBCSIC. His doctorate, defended in 2011, was based on a series of clinical experimental projects on the use of uric acid as a neuroprotective agent in acute ischemic stroke patients treated with systemic thrombolysis (Amaro S, Stroke 2007; Amaro S, Expert Rev Neurother 2008; Amaro S, J Neurol 2009; Amaro S, Int J Stroke 2010; Amaro S, Stroke 2011). This doctoral thesis was awarded as one of the best degrees defended during the year 2011 by the University of Barcelona. From May 2009 to January 2010 he completed a visiting clinical stage at the Neurocritical Care Unit, New York Presvyterian Hospital, Columbia University Medical Center, New York. Recently, SA has been part of the executive committee of the URICOICTUS and CHOICE clinical trials. The clinical research developed by SA along the last years has been focused in the use of advanced neuroimaging techniques and the search for novel therapeutic strategies in the field of acute ischemic and hemorrhagic stroke. He has received continuous competitive funding from the ISCIII as principal investigator for academic research projects starting in 2014. He is also a member of the Ethics Committee of Hospital Clínic of Barcelona since February 2017 and an Associate Professor of Medicine in the University of Barcelona starting in November 2020.